ArticleTrials2023

Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the "KetHead" trial.

Yasmine Hoydonckx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.